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The aim of this study was to investigate oral yeast colonization and oral yeast strain diversity in irradiated
(head and neck), dentate, xerostomic individuals. Subjects were recruited from a nasopharyngeal carcinoma
clinic and were segregated into group A (age, <60 years [n 5 25; average age 6 standard deviation {SD}, 48 6
6 years; average postirradiation time 6 SD, 5 6 5 years]) and group B (age, >60 years [n 5 8; average age 6
SD, 67 6 4 years; average postirradiation time 6 SD, 2 6 2 years]) and were compared with age- and
sex-matched healthy individuals in group C (age, <60 years [n 5 20; average age 6 SD, 44 6 12 years] and
group D (age, >60 years [n 5 10; average age, 70 6 3 years]). Selective culture of oral rinse samples was
carried out to isolate, quantify, and speciate yeast recovery. All test subjects underwent a 3-month compre-
hensive oral and preventive care regimen plus topical antifungal therapy, if indicated. A total of 12 subjects
from group A and 5 subjects from group B were recalled for reassessment of yeast colonization. Sequential
(pre- and posttherapy) Candida isolate pairs from patients were phenotypically (all isolate pairs; biotyping and
resistotyping profiles) and genotypically (Candida albicans isolate pairs only; electrophoretic karyotyping by
pulsed-field gel electrophoresis, restriction fragment length polymorphism [RFLP], and randomly amplified
polymorphic DNA [RAPD] assays) evaluated. All isolates were Candida species. Irradiated individuals were
found to have a significantly increased yeast carriage compared with the controls. The isolation rate of Candida
posttherapy remained unchanged. A total of 9 of the 12 subjects in group A and 3 of the 5 subjects in group
B harbored the same C. albicans or Candida tropicalis phenotype at recall. Varying degrees of congruence in the
molecular profiles were observed when these sequential isolate pairs of C. albicans were analyzed by RFLP and
RAPD assays. Variations in the genotype were complementary to those in the phenotypic characteristics for
some isolates. In conclusion, irradiation-induced xerostomia seems to favor intraoral colonization of Candida
species, particularly C. albicans, which appeared to undergo temporal modifications in clonal profiles both
phenotypically and genotypically following hygienic and preventive oral care which included topical antifungal
therapy, if indicated. We postulate that the observed ability of Candida species to undergo genetic and
phenotypic adaptation could strategically enhance its survival in the human oral cavity, particularly when
salivary defenses are impaired.
Nasopharyngeal carcinoma (NPC) is prevalent among peo-
ple living in southern China. For instance, in Hong Kong, the
age-standardized incidence rates of NPC are 23 and 9 per
100,000 for males and females, respectively (13). Radiotherapy
is the treatment of choice for this condition, as surgical resec-
tion of the lesion is rarely possible. Such irradiation, however,
inevitably involves oral and facial structures, including the ma-
jor salivary glands, that cross the irradiation path. One major
sequel of radiotherapy is prolonged xerostomia (7). Human
saliva helps regulate oral health by its moisturizing, lubricating,
buffering, and antimicrobial properties (43), and qualitative
and quantitative changes in saliva inevitably affect oropharyn-
geal physiology, defense, and microbial ecology (5, 37).
Oral candidiasis is one of the most common fungal infec-
tions of man and is manifested in a variety of clinical presen-
tations. Candida albicans is the main Candida species residing
in the oral cavity and is responsible for the majority of such
infections, although non-C. albicans species are sometimes im-
plicated (30). The former opportunistic, dimorphic fungus is
notable for causing local or systemic infections in an ever-
increasing number of medically compromised individuals (2,
30). These include individuals undergoing chemotherapy, im-
munosuppressive treatment, or long-term broad-spectrum an-
tibiotic therapy; patients with human immunodeficiency virus
infection or advanced neoplasms; and organ transplant recip-
ients. Being opportunistic pathogens, Candida species flourish
and cause a spectrum of diseases in these individuals (2, 29),
especially when immunological defenses are impeded (12).
Oral candidiasis is common in individuals with head, neck,
and other malignancies, especially when radiotherapy is used
as the mainstay of treatment (8, 28, 37). It is thought that
irradiation-induced histologic changes leading to oral mucosi-
tis, together with quantitative and qualitative changes in saliva
and salivary flow, facilitate yeast infection (9). In a very recent
study which monitored the weekly oral yeast carriage in 30
patients with head and neck cancers undergoing irradiation
therapy, Redding and coworkers (28) noted oral Candida car-
riage in 73% of patients on at least one visit and when those
positive for Candida were recalled, the researchers noted oral
Candida carriage at 51% of the recall visits (28). Further, they
reported that almost identical Candida strains consistently col-
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onized the oral cavity despite the use of antifungals by 27% of
the study population. However, there are others who were
unable to note any discernible differences in oral yeast coloni-
zation in control and test subjects after radiation therapy (38).
Possible reasons for such discrepant results may be the intrin-
sic differences in the study populations and the irradiation
protocols used (8, 9, 28, 38).
The aims of the present study, therefore, were to investigate
the oral colonization profile of yeasts (i) in a homogenous
cohort with a history of NPC managed using a similar irradi-
ation protocol, at least 6 months following irradiation therapy,
and (ii) before and after professional oral hygienic care either
with or without antifungal therapy. In addition, the phenotypic
and genotypic characteristics of sequential yeast isolates from
a subgroup of studied individuals were monitored to explore
the degree of similarity between isolates.
MATERIALS AND METHODS
Study group. A total of 33 patients who survived NPC (confirmed by two
consecutive negative biopsies 10 weeks apart starting at week 8 postirradiation)
6 or more months posttreatment were recruited from the Department of Clinical
Oncology, Queen Mary Hospital, the University of Hong Kong (34). All subjects
underwent almost identical radiotherapy protocols, and the total irradiation dose
received was similar (34). The irradiated subjects were divided into two cohorts
according to age (group A [,60 years] and group B [$60 years]), with reference
to a previous study design (14, 16). Age- and sex-matched nonirradiated indi-
viduals were selected for the control groups, as follows: 20 subjects younger than
60 years old were randomly selected from the Outpatient Dental Clinic, Faculty
of Dentistry, the University of Hong Kong (group C) and 10 healthy males 60
years of age or older were randomly selected from more than 100 attendees at a
local senior community center (group D).
Clinical examination, treatment, and recall. At baseline, a comprehensive
clinical examination was carried out for all subjects. The detailed data from this
examination, including the plaque index (35) and gingival index (17), which are
indicators of personal oral hygiene, have been reported elsewhere (34). All
subjects in groups A and B were given comprehensive oral health care which
included oral hygiene education, daily home fluoride gel application, scaling and
polishing of the teeth, restoration of carious lesions, and topical antifungal
therapy for those with clinically evident oral candidiasis; jaw muscle exercises
were prescribed for subjects with trismus. Three months after completion of this
comprehensive oral care regime, all subjects in groups A and B were invited for
a review of their oral cleanliness and to repeat the oral rinse sampling (see
below).
Sampling. To evaluate yeast carriage, oral rinse samples were obtained as
described by Samaranayake et al. (31), with slight modifications. In brief, the
subjects were asked to rinse their mouth for 60 s with 10 ml of sterile 0.01 M
phosphate-buffered saline, pH 7.2. Denture-wearing subjects did not remove
their prostheses. After 60 s the subjects expectorated the oral rinse into a sterile
universal container, which was then immediately transported to the laboratory
for processing.
Culture and identification of isolates. All samples from groups C and D were
centrifuged at 1,700 3 g for 10 min. The pellet was resuspended in 2.5 ml of
phosphate-buffered saline, pH 7.2, and vortexed at the maximum setting for 30 s
(Autovortex Mixer SA2; Stuart Scientific, London, United Kingdom). Samples
from groups A and B were used neat, as a pilot study indicated very high
numbers of yeast in the oral rinse samples, rendering the concentration step
unnecessary (data not shown). Volumes (50 ml) of each of the unconcentrated
(groups A and B) and the resuspended (groups C and D) oral rinses were spiral
plated (model DU; Spiral Systems Inc., Cincinnati, Ohio) onto duplicate Sab-
ouraud’s dextrose agar (Oxoid, Hampshire, United Kingdom) and incubated for
18 h at 37°C. The number of CFU for each sample was quantified, and five
colonies per sample were randomly selected and subcultured to obtain a pure
growth (in specimens with five or fewer colonies, all CFU were subcultured).
The organisms were identified and speciated based on the following: colony
morphology, cell morphology, gram staining reaction, and germ tube test (18);
API 20C AUX and API ZYM tests (Analytical Profile Index; Bio Me´rieux SA,
Marcy l’Etoile, France). Isolates from a single sample yielding identical API 20C
AUX and API ZYM profiles were considered the same yeast strain. Broth
cultures of pure isolates were aliquoted and stored as stock cultures at 270°C
and were later retrieved for biotyping, resistotyping, and molecular character-
ization.
Biotyping. All C. albicans isolates from pre- and post-antifungal and/or hy-
gienic therapy were biotyped using the API 20C AUX and API ZYM (Analytical
Profile Index; Bio Me´rieux SA) systems according to the methods described by
Williamson et al. (46) and Matee et al. (21). All tests were performed according
to the manufacturer’s instructions using a standardized inoculum, temperature,
and duration of incubation. Repeat biotyping was performed three times to
ascertain the reproducibility of the results.
Resistotyping. All Candida isolates were resistotyped by the method of Mc-
Creight et al. (23) using acrylamide, boric acid, cetrimide, chlorhexidine, copper
(II) sulphate, sodium chloride, sodium periodate, and sodium selenite. The
concentration of each chemical (except chlorhexidine) which inhibited the
growth of up to 50% of the isolates was recorded as the breakpoint concentra-
tion. The ability of the isolates to grow on MacConkey agar was also tested. The
resistotyping profile of each isolate was confirmed by repeat experiments on
three separate occasions.
Preparation of Candida DNA for molecular analysis. C. albicans isolates ob-
tained from the stock culture were subcultured on yeast-peptone-dextrose me-
dium (1% peptone, 1% yeast extract, 2% glucose, 1.5% agar) at 37°C for 24 h.
A single colony was transferred to 20 ml of yeast-peptone-dextrose broth and
incubated at 30°C in air with constant shaking until the early stationary phase
(monitored by measurement of optical density at 600 nm) was reached. The yeast
cells were harvested by centrifugation at 4,000 3 g for 5 min and then washed in
1 M sorbitol (4). For randomly amplified polymorphic DNA (RAPD) or restric-
tion fragment length polymorphism (RFLP) analysis, the yeast pellet was resus-
pended in 1.5 ml of SE buffer (1.2 M sorbitol–0.1 M EDTA, pH 8.0) containing
3 ml of b-mercaptoethanol (Sigma, St. Louis, Mo.) and 0.5 mg of yeast lytic
enzyme (lyticase; Sigma) and incubated at 37°C for up to 1 h until spheroplasts
were noted. The spheroplasts were harvested by centrifugation at 2,500 3 g for
5 min, washed twice in SE buffer, and resuspended in 1.5 ml of 0.15 M NaCl–0.1
M EDTA, pH 8.0. They were then lysed by the addition of proteinase K (final
concentration, 500 mg/ml) and sodium dodecyle sulfate (final concentration, 1%
[wt/vol]), along with RNase (final concentration, 500 mg/ml), at 55°C for 1 h. The
lysed C. albicans spheroplasts were pelleted at 13,000 3 g for 5 min, and then the
supernatant was extracted twice with phenol and once with phenol-chloroform
prior to DNA precipitation by the addition of an equal volume of 2-propanol.
The precipitated DNA was redissolved in 100 ml of TE buffer (0.1 mM EDTA–10
mM Tris, pH 8.0) (4).
Chromosomal analysis by pulsed-field gel electrophoresis (PFGE). Cell sus-
pensions in 1 M sorbitol prepared as described above were washed twice in 50
mM EDTA–10 mM Tris, pH 7.6, and resuspended to a concentration of 109
cells/ml in 50 mM EDTA, pH 8.0. A 500-ml volume of this suspension was mixed
with 50 ml of 3 mg of lyticase (Sigma) per ml of solution (900 U of lyticase/ml)
and 550 ml of 1% low-melting-point agarose in 20 mM NaCl–0.5 M EDTA–10
mM Tris, pH 7.6. The resulting agarose plugs were incubated in 50 volumes of
7.5% b-mercaptoethanol–0.5 M EDTA–10 mM Tris, pH 7.6, two times for 24 h
each time for spheroplast generation. The plugs (100 ml) were then suspended in
100 ml of solution containing 1% laurylsarcosine and 100 mg of proteinase K and
then incubated first at 50°C for 24 h and then at 50°C for 24 h in 100 mg of
proteinase K solution alone (26, 32). Alternatively, after the lyticase digestion,
the agarose plugs containing the spheroplasts were lysed in 1% sodium dodecyl
sulfate–20 mM NaCl–0.5 M EDTA–10 mM Tris, pH 7.6, at 37°C overnight. Then
the plugs were washed thrice with 50 mM EDTA, pH 8.0, and loaded onto 0.8%
(wt/vol) chromosome-grade Ultra-pure agarose gel (Bio-Rad Laboratories, Her-
cules, Calif.) in TBE buffer (0.53 TBE buffer is 2.5 mM EDTA–89 mM boric
acid–89 mM Tris, pH 8.0) (26, 32).
The chromosomes of C. albicans were separated employing the contour-
clamped homogeneous electric field (CHEF) technique using the CHEF-DR III
variable angle system (Bio-Rad) in 0.53 TBE buffer at 14°C. The electrophoretic
conditions used were as follows: two-state mode with linear ramping factors; run
time, 48 h; initial and final switching times, 90 s and 325 s, respectively; constant
voltage of 4 V/cm, switching angle, 120 degrees. Hansenula wingei chromosomes
(Bio-Rad) were used as the molecular size standard. The resulting gel was
stained with ethidium bromide (0.5 mg/ml of distilled water; Sigma) for 15 min
and destained in distilled water for 3 h. DNA bands were visualized and photo-
graphed under UV transillumination. Each specimen was analyzed on at least
three separate occasions.
RFLP. Total genomic DNA of the C. albicans isolates was digested to com-
pletion with the restriction enzyme HinfI according to the method described by
Smith et al. (36). In brief, after quantification of the DNA specimens (32), 10 mg
of the DNA was incubated with 10 U of HinfI (Pharmacia) for 6 h at 37°C
according to the manufacturer’s instructions. The digests were electrophoresed
in a 1.2% (wt/vol) agarose gel containing ethidium bromide in 0.53 TBE buffer
at 50 V for 4 h and visualized under UV transillumination (4). The RFLP
analysis was repeated on two more separate occasions.
RAPD analysis. The custom-synthesized primers (Gibco BRL; Hong Kong)
used in the study were NA (the initials of N. Akopyanz) (59GCGATCCCCA39)
(1), JWFR (the initials of J. W. Fell plus R for reverse) (59GGTCCGTGTTTC
AAGACG39) (10), and JWFF (F for forward) (59GCATATCAATAAGCGGA
GGAAAAG39) (10). Thermocycling was performed in a minicycler machine
(models PTC-150-16 and 25; MJ Research, Watertown, Mass.). A 50-ml volume
of the PCR master mix contained approximately 200 ng of yeast DNA template,
5 ml of PCR buffer (103 PCR buffer is 0.5 M KCl–0.2 M Tris (pH 8.4), a 200 mM
concentration of each dNTP, 25 mM MgCl2, a 1 mM concentration of primer,
and 1.5 U of Taq polymarase (Life Technologies, Frederick, Md.). The first five
cycles of PCR protocol included 30 s of denaturation at 94°C and 2 min of
annealing at 27°C (primer NA) or 52°C (primers JWFR and JWFF); this was
followed first by 2 min of primer extension and then by 45 cycles of 30 s of
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denaturation at 94°C, 2 min of annealing at 32°C (primer NA) or at 57°C
(primers JWFR and JWFF), and 2 min of primer extension at 72°C. The reaction
was held at 72°C for 15 min. Control tubes without template DNA were included
in each run, and reproducibility was checked for each reaction (39). The PCR
products were electrophoresed in an 0.8% agarose gel in TBE buffer, stained
with ethidium bromide, and visualized under UV transillumination. The RAPD
analysis was repeated on two further separate occasions with strains recovered
from the stock kept at 270°C.
Statistics. The demographic and microbiological data of the subjects were
analyzed by Statview 4.5 for Macintosh computer. Differences between individ-
ual groups were tested by Bonferroni’s multiple comparison for nonparametric
data, analysis of variance, or Fisher exact test, as appropriate. Groups were
regarded as significantly different from each other if P was ,0.05.
RESULTS
The demographic data of the subjects recruited in the first
part of the study, including the length of the postirradiation
period, are shown in Table 1. On initial examination, 42%
(group A [n 5 10], 40%; group B [n 5 4], 50%) of the irradi-
ated individuals were diagnosed as having oral candidiasis.
All isolates belonged to Cryptococcoideae and were Candida
species. The species isolated were C. albicans (group A [n 5
19], 76%; group B [n 5 5], 62.5%; group C [n 5 2], 10%; group
D [n 5 4], 40%), C. tropicalis (group A [n 5 5], 20%; group B
[n 5 4], 50%; groups C and D [n 5 0], 0%), Candida parap-
siolosis (group A [n 5 2], 8%; group C [n 5 1], 5%; groups B
and D, [n 5 0], 0%), Candida famata (group A [n 5 1], 4%;
groups B, C, and D [n 5 0], 0%). Two species of Candida were
isolated from each of two rinse samples from group A and one
rinse sample from group B. Significantly higher prevalences of
C. albicans, C. tropicalis, and total Candida species were noted
in the irradiated individuals (groups A and B) than in the
healthy individuals (groups C and D) (Fisher exact test, P ,
0.05). The total counts (in CFU per milliliter of oral rinse) of
yeast species isolated are summarized in Table 2. The oral
rinse samples of irradiated individuals, (i.e., groups A and B),
yielded a mean of at least one yeast species as opposed to less
than 0.5 yeast species recovered from groups C and D (Table
2). The quantities (in CFU per milliliter) of total Cryptococ-
coideae recovered from Group B subjects were significantly
elevated compared with those recovered from the other three
cohorts (Table 2).
Altogether, 12 (6 males; average age 6 SD, 45.9 6 5.8 years;
average postirradiation time 6 SD, 5.0 6 3.1) and 5 (all males;
average age 6 SD, 67.1 6 3.4 years; average postirradiation
time 6 SD, 2.0 6 1.1 years) subjects from groups A and B,
respectively, participated in the recall reassessment for yeast
colonization. The remainder either missed the recall, attended
their own general dentist, or succumbed to illness. Clinically,
most of the subjects exhibited a fair standard of oral hygiene,
i.e., $81% of the studied sites had a plaque index score of #1
during both examination events, with the number of plaque-
free sites increasing from 12% to 33% at the second examina-
tion. As for periodontal health, $69% of the studied sites
exhibited clinically healthy or mild marginal gingival swelling
without bleeding on probing; 95% of sites were free of calculus
at the initial examination. On first presentation 35.3% (group
A, n 5 4; group B, n 5 2), i.e., 6 of the 17 individuals were
clinically diagnosed with candidiasis and received topical anti-
fungal therapy (100,000 U of nystatin per gram of ointment,
three times a day [20]), whereas at the recall session, 23.5%
(group A, n 5 3; group B, n 5 1), i.e., 4 of the original 6
subjects remained affected by candidasis, albeit with markedly
smaller lesions. Antifungal therapy was helpful in eradicating
the yeast or reducing the yeast numbers to below detectable
levels in only 1 of the 6 individuals. In four cases, the coloni-
zation pattern remained unchanged while in one case C. albi-
cans was replaced by C. tropicalis on the second sampling visit.
None of the affected individuals complained of discomfort
related to the residual lesions at the recall session.
Eight of the 11 asymptomatic individuals harbored the same
biotype of Candida in the sequential oral rinse samples (C.
albicans, n 5 7; C. tropicalis, n 5 1), while the remainder
yielded different Candida species on the second visit (one
yielded C. albicans and then C. tropicalis, one yielded C. tropi-
calis and then C. albicans, and one yielded C. albicans and then
C. glabrata).
The prevalences of yeast species in oral rinse samples at
baseline and recall sessions is summarized in Table 3. The
quantity of yeast species isolated from both groups (total or
individual counts), from the first or second oral rinse samples,
irrespective of antifungal therapy, fell within a similar range.
The range and median values (in CFU per milliliter of oral
rinse) were determined for C. albicans before (range, 0 to
4.8 3 104; median, 132) and after (range, 0 to 1.2 3 104;
median, 711) treatment and for C. tropicalis before (range, 0 to
2.3 3 104; median, 0) and after (range, 0 to 4.5 3 103; median,
0) treatment. There was no significant difference in either the
yeast recovery patterns or the yeast harvests between the two
visits.
The 10 sequential isolate-pairs of C. albicans were biotyped
using the API 20C AUX and API ZYM kits. All were found to
belong to the primary biotype type J of the classification system
of Williamson et al. (46) (Table 4), indicating that they all
possessed alkaline phosphatase, acid phosphatase, esterase,
TABLE 1. Demographic data of the cohorts studied
Characteristic
Value for groupa
A B C D
Age 48.1 6 5.7 66.5 6 3.5 43.9 6 11.8 69.5 6 3.3
Total subjects 25 8 20 10
Male (%) 64 100 60 100
Wearing denture (%) 8 25 10 80
Postirradiation time
Range 0.5–19.2 0.5–3.4
Mean 6 SD 4.9 6 4.5 1.8 6 1.1
a Please refer to text for definition of groups.
TABLE 2. Quantity of Cryptococcoideae isolated from oral
rinse samplesa
No. of CFU/ml of
oral rinse
Value for group
A B C D
Cryptococcoideae spp.b
Range 20–105 20–1.3 3 105 0–81 0–1.52 3 104
Median 1,057 4,406 0 0
Candida albicansc
Range 0–4.81 3 104 0–1.04 3 105 0–81 0–1.52 3 104
Median 244 102 0 0
Candida tropicalisc
Range 0–105 0–1.3 3 105 0 0
Median 0 1 0 0
a Please refer to text for definition of groups. The number of Cryptococcoideae
species per sample was as follows (values are means 6 SD): for group A, 1.08 6
0.28; for group B, 1.13 6 0.35; for group C, 0.15 6 0.37; and for group D, 0.40 6
0.52. There was a significant different (P , 0.05 by Bonferroni’s multiple com-
parison) in data values between groups A and C, A and D, B and C, and B and
D.
b Significant difference (P , 0.05 by Bonferroni’s multiple comparison) in data
values between groups A and B, B and C, and B and D.
c Only yeast species with a prevalences of $15% are included.
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lipase esterase, leucine arylamidase, valine arylamidase, phos-
phoamidase, a-glucosidase and N-acetyl-b-glucosaminidase
activity (data not shown). Eight sequential isolate pairs be-
longed to the secondary biotype 1 (per API 20C AUX), while
the remainder were of biotypes 11 and 24 (21) (Table 4).
The resistotype profiles of the 12 sequential isolate pairs of
C. albicans and C. tropicalis are also shown in Table 4. The
susceptibilities of the isolate pairs to various chemicals differed
to varying extents. Five of the 12 isolate pairs tested were of
resistotypes that were considerably different (.3 of 9 tests)
from those of their counterparts. It was found that among
individuals receiving only hygienic therapy C. albicans isolate
pairs with fewer phenotypic differences were significantly more
prevalent than they were among subjects that received anti-
fungal therapy (Table 4).
The 10 sequential C. albicans isolate pairs from the irradi-
ated patients were subjected to three different molecular typ-
ing methods, namely, PFGE, RFLP, and RAPD analyses.
Identical banding patterns were observed in specimens from
the same stock culture (data not shown). Electrophoretic
karyotyping using PFGE revealed six to eight chromosomes
per C. albicans isolate tested, with chromosome sizes ranging
from 1 to 3.2 Mb. All but two isolate-pairs (L1-L19 and L2-L29)
revealed stringent conservation of karyotypes (Fig. 1). When
comparing PFGE patterns of isolates from different subjects,
only isolates from subjects L8 and L10 showed identical PFGE
profiles (Fig. 1B). The restriction enzyme HinfI was employed
to further profile the isolates by genotype (3, 6, 36). Enzymatic
digestion of sequential C. albicans isolate pair DNA specimens
by HinfI revealed that 7 of 10 patients carried genetically
different strains after the antifungal and/or hygienic therapy as
illustrated by the polymorphism of restriction fragments at the
higher-molecular-weight region, i.e., 2 to 10 kb (6). The re-
maining 30% of the DNA profiles exhibited almost identical
restriction fragment length patterns (Table 5; Fig. 2).
When the 10 sequential C. albicans isolate-pairs were ana-
lyzed by RAPD, remarkable genetic variation was observed
(Table 5). The three different primers yielded isolate-specific
arrays of 10 to 15 prominent fragments under the PCR condi-
tions employed (Fig. 3). Only one isolate pair was found to
possess identical DNA profiles when the primers NA and
JWFR were used (Fig. 3). However, with the primer JWFF,
four C. albicans isolate pairs were found to be identical, al-
though none of these was the pair which was deemed identical
with NA and JWFR (Table 5).
DISCUSSION
The prevalence and quantity of cultivable oral yeasts and
their colonization patterns in a homogenous group of NPC
survivors subjected to therapeutic head and neck irradiation
were investigated by using a cross-sectional study design. To
our knowledge this is the first study to characterize sequential
oral Candida isolates from irradiated individuals suffering from
solid tumors similar in nature and subjected to the same ther-
apeutic irradiation protocol. The baseline data obtained were
compared with data for age- and sex-matched nonirradiated
healthy individuals. The oral yeast colonization pattern of the
irradiated subjects after antifungal and/or hygienic therapy was
reassessed, and the phenotypic and genotypic characteristics of
biochemically identical, sequential oral yeast isolate pairs were
studied.
The oral yeast colonization profile, including the candidal
prevalence and the predominant Candida species isolated,
from our test cohort was similar to most previous reports from
irradiated subjects with various head and neck tumors (20, 27).
According to some reports, early oral candidal colonization in
these patients coincides with the commencement of irradiation
therapy (28). In our study topical antifungal therapy effectively
reduced lesion sizes and resolved clinical symptoms in approx-
imately one-third of the recalled patients with candidasis, al-
though the oral yeast prevalence was persistently high (Table
3). Similarly, Ramirez-Amador et al. (27) have shown that
systemic antifungal therapy eradicated clinical oral infection in
only five of eight irradiated patients. In another recent study
Redding et al. (28) reported that progressive, incremental sys-
temic antifungal dosage could eliminate only 27% of clinical
Candida infections, and oral yeast carriage cannot be totally
eradicated. Based on these observations, and mindful of the
selection and emergence of drug-resistant strains, both groups
expressed caution in using prophylactic antifungals during ir-
radiation therapy (27, 28).
It is well established that Candida species are oral commen-
sals in diseased individuals such as the irradiated subjects in
the current study. Hence, one premise of our study was that the
Candida strains isolated on the recall visit were persistent oral
strains derived from the original parent stock but subjected to
exogenous insult such as postirradiation xerostomia. Particular
attention was paid in studying these sequential yeast isolates in
an attempt to trace their phenotypic and genotypic lineage.
Thus, we found that 59% of the recalled subjects harbored C.
albicans and 12% harbored C. tropicalis, respectively, at both
time points studied. Although the introduction of exogenous
Candida strains into the oral cavity between the sampling in-
tervals cannot be totally ruled out, this would be minimal, as all
subjects suffered from the same type of tumor (NPC), success-
fully treated with a single course of irradiation therapy without
resorting to surgery, immunosuppressants, or long-term ste-
roid therapy. Second, the subjects were all from southern
China, having comparable dietary habits. All had undergone
similar, professionally delivered oral hygiene therapy.
Although, it would have been desirable to follow up both the
control and the test group to decipher the lineage of sequential
oral Candida isolates, we did not, due to the low prevalence of
oral yeasts in control group C (age, #60 years). Furthermore,
the fact that the denture-wearing habit, which fosters yeast
colonization, was more prevalent in control group D (age, $60
years) reinforced our decision to abort such a parallel study.
Resistotyping allows differentiation of C. albicans isolates
from clinical samples and has been used in clinical epidemiol-
ogy studies (24). This method is based on the susceptibility of
the test strains to a select group of organic and inorganic
TABLE 3. Frequencies of yeast species isolated from oral rinse
samples of irradiated individuals before and after antifungal
and/or hygienic therapy
Species
Frequency (%)
Before therapya After therapy
Group A Group B Group A Group B
Candida albicans 75.0 80.0 83.3 40.0
Candida glabrata 0 0 8.3 20.0
Candida lipolytica 0 0 0 20.0
Candida tropicalis 25.0 40.0 16.7 20.0
Total Cryptococcoideae 100.0 100.0b 100.0b 80.0b
a Group A, n 5 12; Group B, n 5 5. Data from subjects who participated both
before and after antifungal and/or hygienic therapy were considered.
b Some samples contained more than a single species, so the total is not equal
to the sum of the frequencies for individual species.
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compounds incorporated into specific culture media. The res-
istotype profiles of the isolate pairs studied showed varying
degrees of difference (Table 4). Distinctly different resistotypes
were obtained with C. albicans isolate pairs L4-L49, L8-L89,
L9-L99, and L10-L109; the last three being from subjects who
had received topical antifungal therapy. The rest of the isolate
pairs were found to be moderately or minimally different from
their partner strain. The C. tropicalis isolate pair, L11-L119,
was found to differ in resistotype after hygienic therapy, while
the isolate pair L12-L129 was minimally different despite anti-
fungal therapy (Table 4).
Due to the potential inconsistencies of the phenotyping
methods, several molecular typing methods have been widely
used in epidemiologic studies of C. albicans. These include
RAPD (22), RFLP analysis of total genomic DNA (40), South-
ern hybridization analysis using a number of different probes
(11, 33), and electrophoretic karyotyping using PFGE (25).
However, the resolution, specificity, and discriminatory power
of each of these methods differ greatly, thus affecting their
utility. For instance, electrophoretic karyotyping of chromo-
some-size DNA elements of medically important yeasts is of-
ten used to evaluate species and strain profiles (26) and this
technique is considered one of the better molecular typing
methods available to study the genetics of C. albicans (15). A
relatively less technically demanding approach for strain dif-
ferentiation of C. albicans is RFLP analysis (36). HinfI used in
TABLE 4. Phenotypic characteristics of sequential isolate pairs of Candida spp. derived from oral rinse samples
Species and
isolate no.
API 20C
AUX profile
Resistotypea Overall
difference
(%)bACR BA CET CHX CuSO4 NaCl NaIO4 Na2SeO3 Mac
C. albicansc
L1d 2576174 (1) (1) (1) 1 1 1 1 1 1 9L19 2576174 2 2 2 1 2 1 1 1 1
L2 2576174 2 2 2 (1) 2 1 2 1 1 9L29 2576174 (1) 2 2 1 2 1 2 2 1
L3 2576174 1 2 2 (1) 2 1 2 1 1 18L39 2576174 1 2 2 (1) 1 2 2 1 1
L4 2576174 (1) 2 2 (1) 2 2 1 2 1 36L49 2576174 1 1 1 2 2 1 1 1 1
L5 2576174 2 2 2 2 2 1 2 (1) 2 18L59 2576174 1 2 2 2 2 2 2 2 (1)
L6 2564174 1 (1) 1 1 2 2 2 1 1 18L69 2564174 1 (1) 2 2 2 2 2 1 1
L7 2576174 1 2 2 1 2 2 2 1 1 9L79 2576174 1 2 (1) 2 2 2 2 1 1
L8e 2576174 1 2 2 1 2 (1) 2 1 1 36L89 2576174 2 2 1 2 2 2 2 1 2
L9e 2576174 2 1 1 2 2 2 2 1 2 36L99 2576174 2 2 2 1 2 2 2 1 1
L10e 2566174 1 2 2 2 2 2 1 1 1 45L109 2566174 2 1 2 1 1 2 (1) 2 1
C. tropicalis
L11f 2556171 2 1 2 2 2 2 (1) 2 1 30L119 2556171 2 1 2 1 1 2 1 1 1
L12e 2556371 2 (1) 2 2 2 1 1 1 1 10L129 2556371 1 1 2 2 2 1 1 1 1
a ACR, acrylamide (12 mg/ml); BA, boric acid (2.5 mg/ml); CET, cetrimide (0.2 mg/ml); CHX, chlorhexidine (0.25% [vol/vol]); CuSO4, copper (II) sulphate (2
mg/ml); NaCl, sodium chloride (187.5 mg/ml); NaIO4, sodium periodate (3 mg/ml); Na2SeO3, sodium selenite (7.5 mg/ml); Mac, MacConkey agar; 1, resistant; (1),
intermediately resistant; 2, susceptible.
b Overall difference determined by the API 20C AUX profile and/or the API ZYM profile (C. albicans only) plus the nine resistotyping profiles. For C. albicans, 11
tests were done; for C. tropicalis, 10 tests were done. All tests were assigned the same weighting, with (1) considered indifferent. Considering the difference between
isolate pairs in relation to antifungal therapy versus the overall difference in phenotypic characteristics (dichotomized as follows: an overall difference of ,30% was
considered low and an overall difference of $30% was considered high), significantly less C. albicans phenotypic change (low group) was observed in isolate pairs from
subjects who did not undergo antifungal therapy (Fisher exact test, P 5 0.033)
c All C. albicans species were of API ZYM biotype J (21). The API 20C AUX secondary biotype for isolate pair L6-L69 was 11 (46), for isolate pair L10-L109 was
24 (21) and for all the rest was 1 (46).
d A designation consisting of a letter and a number indicates that the isolate was isolated before antifungal and/or hygienic therapy; a designation consisting of the
same letter and number, as well as a prime symbol, indicates that the isolate was isolated after antifungal and/or hygienic therapy.
e Isolate pairs recovered from subjects who underwent antifungal therapy.
f Isolate collected from a denture wearer.
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the latter method produces a clear background and less-am-
biguous band patterns (36), and this indeed was the case in our
studies. The fragments of interest (in the region of 4 to 9 kb)
generated by HinfI digestion of total genomic DNA are de-
rived from the spacer region of the DNA repeat sequences of
C. albicans (19). Smith et al. (36) postulated that the above-
mentioned spacer region was not genetically conserved, hence
generating the diversity observed.
As opposed to PFGE and RFLP, PCR-based protocols have
become popular in recent years for genotyping Candida (3).
Among them, RAPD is the most favored, probably due to its
relatively simple and quick protocol. One limitation, however,
is that no universally established guidelines are available for
the selection of primers and the subsequent interpretation of
the data generated. Whereas some have used combined pro-
files derived from multiple primers (45), others suggest the use
of a single primer in combination with different molecular
typing methods for profiling Candida genotypes (41). Bart-
Delabesse and coworkers (3) appreciated these difficulties and
suggested that minor variations of RAPD profiles of isolates
derived from the same individual should be disregarded. We
followed these guidelines in the current study, together with
recommendations of Sullivan and coworkers (41), who sug-
gested the selection of at least three different molecular typing
methods for adequate characterization of C. albicans.
At the karyotype level, only C. albicans isolate pairs L1-L19
and L2-L29 appeared to yield disparate profiles, in contrast to
all other isolate pair profiles, which were identical (Fig. 1). A
total of 11 unique C. albicans karyotypes were observed in this
study, including four isolates (isolate pairs L8-L89 and L10-
L109) with the same karyotype profile (Fig. 1; Table 5). Inter-
estingly, isolate pairs L8-L89 and L10-L109 were dissimilar with
regard to their (API 20C AUX) biotype.
The banding profiles of C. albicans we obtained using PFGE
were similar in size range to those observed by Bostock et al.
FIG. 1. Pulsed-field gel electrophoretic separation of chromosome-sized
DNA of sequential C. albicans isolate pairs from oral rinse samples. (A) Karyo-
types of isolates from subjects 1 to 5 before (lanes L1, L2, L3, L4, and L5) and
after (lanes L19, L29, L39, L49, and L59) antifungal and/or hygienic therapy. (B)
Karyotypes of isolates from subjects 6 to 10 before (lanes L6, L7, L8, L9, and
L10) and after (lanes L69, L79, L89, L99, and L109) antifungal and/or hygienic
therapy. Karyotyping was carried out on an 0.8% agarose gel. Lane M, H. wingei
chromosome molecular size standard (Bio-Rad).
FIG. 2. RFLP of C. albicans DNA digested by HinfI. Shown are DNA frag-
ments obtained from digestion of DNA extracted from five patients, subjects 6 to
10, before (lanes L6, L7, L8, L9, and L10) and after (lanes L69, L79, L89, L99, and
L109) antifungal and/or hygienic therapy. DNA bands were visualized by elec-
trophoretic separation on a 1.2% agarose gel. Lane M, l DNA HindIII digestion
standard.
TABLE 5. Genotypic similarities of C. albicans sequential isolate
pairs derived from oral rinse samples
Isolate
pairc
Profile by:
PFGE RFLPa
RAPDb
NA JWFR JWFF
L1-L19 2d 2 2 2 1
L2-L29 2 1 2 2 1
L3-L39 1 2 2 2 1
L4-L49 1 2 2 2 2
L5-L59 1 2 2 2 1
L6-L69 1 2 1 2 2
L7-L79 1 2 2 1 2
L8-L89 1 1 2 2 2
L9-L99 1 2 2 2 2
L10-L109 1 1 2 2 2
a RFLP profile generated by digestion with HinfI (35).
b RAPD profiles were generated with three different primers: NA (59GCGA
TCCCCA39) (1), JWFR (59GGTCCGTGTTTCAAGACG39), and JWFF (59G
CATATCAATAAGCGGAGGAAAAG39) (10). Observable band staining in-
tensity differences and variation of one band were disregarded (3).
c A designation consisting of a letter and a number indicates the isolate was
isolated before antifungal and/or hygienic therapy; a designation consisting of the
same letter and number, as well as a prime symbol, indicates that the isolate was
isolated after antifungal and/or hygienic therapy.
d 2, the isolates in the pair were not identical; 1, the isolates in the pair were
identical.
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(4). Minor differences noted in the profiles of isolates L1, L19,
L2, and L29 (Fig. 1A) could possibly be due to chromosome
translocation giving rise to the chromosome length polymor-
phism (44). Another possibility is that genetically similar, yet
slightly divergent, C. albicans strains were colonizing these
individuals on two different occasions.
With respect to the HinfI RFLP profiles of the C. albicans
isolate pairs, it was intriguing to note the wide variations of the
sequence of the spacer region of the ribosomal DNA (rDNA)
repeat (Table 5). According to this protocol, only 3 of 10
isolate pairs were similar, whereas in the PFGE protocol 8 of
10 pairs showed close resemblance. Furthermore, congruence
of isolate pairs when using both the PFGE and RFLP methods
was seen only with the isolate pairs L8-L89 and L10-L109.
When the RAPD protocol was used to further characterize
the Candida, all three primers yielded more or less similar
numbers of fragments (Fig. 3). The primers used in our study
were derived from a battery of primers employed for charac-
terization of Candida dubliniensis (42), and were of varying size
and GC content, i.e., NA, JWFR, and JWFF contained 10
bases with a GC content of 70%, 18 bases with a GC content
of 55%, and 24 bases with a GC content of 42%, respectively.
The rationale for using primers JWFR and JWFF was their
previous utility in the analyses of the V3 variable region of the
large ribosomal subunit genes of C. albicans (10, 42). In the
current study, JWFR and JWFF were used individually rather
than in tandem as previously described (10, 42) in an attempt
to generate an extra set of RAPD profiles. NA has also been
previously employed for RAPD fingerprinting of C. albicans
(1). All primers employed appeared to well suit the present
analyses, as they yielded effectively similar annealing frequen-
cies in most of the C. albicans isolates tested.
Drawing together the phenotypic and genotypic character-
istics of the C. albicans isolate pairs studied, we could make the
following conclusions. The chromosomal attributes of the se-
quential C. albicans isolate pairs appear relatively subject spe-
cific (except for the two pairs L8-L89 and L10-L109). There was
no significant disparity in the chromosome-size bands derived
from PFGE, except for the possibility of chromosomal trans-
locations observed in two isolate pairs. As for RAPD analyses,
identical genotypic characteristics could be detected only in six
isolate pairs with all three primers. Further, the utility of the
HinfI RFLP regimen for profiling C. albicans genotype appears
questionable, as there was no correlation between the latter
and the HinfI RFLP profile for any of the isolate pairs tested
(Tables 4 and 5). This may be due to the characteristics of the
highly variable rDNA spacer region, the use of which may
confer minimal effects on the C. albicans phenotype.
In conclusion, we postulate that the irradiation-induced
changes of the intraoral environment, such as xerostomia, lead
to increased intraoral colonization by Candida species. The
question of whether clonal selection and propagation of Can-
dida occurs in these patients either due to irradiation and/or to
concomitant antifungal therapy is still unresolved. A compre-
hensive study of a large cohort using precise analytical tools
appears to be necessary to resolve this issue.
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FIG. 3. RAPD fingerprinting patterns of sequential C. albicans isolate pairs
with primers NA (59GCGATCCCCA39) (A) (amplification patterns of isolates
from five patients, subjects 6 to 10, before [lanes L6, L7, L8, L9, and L10] and
after [lanes L69, L79, L89, L99, and L109] antifungal and/or hygienic therapy),
JWFR (59GGTCCGTGTTTCAAGACG39) (B) (amplification patterns of iso-
lates from five patients, subjects 1 to 5, before [lanes L1, L2, L3, L4, and L5] and
after [lanes L19, L29, L39, L49, L59] antifungal and/or hygienic therapy), and
JWFF (59GCATATCAATAAGCGGAGGAAAAG39) (C) (amplification pat-
terns of isolates from five patients, subjects 6 to 10, before [lanes L6, L7, L8, L9,
and L10] and after [lanes L69, L79, L89, L99, and L109] antifungual and/or
hygienic therapy). PCR products were electrophoretically separated on a 1.2%
agarose gel. Lane M, 123-bp DNA ladder (Sigma) (in panel A); PCR marker
(Sigma) (in panels B and C).
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